Epigenetic control of exercise training-induced cardiac hypertrophy by miR-208

Clinical Science

Volumn 130, Issue 22, 2016, Pages 2005-2015

  Soci, Ursula Paula Renó ^a   Fernandes, Tiago ^a   Barauna, Valerio Garrone ^b   Hashimoto, Nara Yumi ^a   Mota, Gloria de Fátima Alves ^a   Rosa, Kaleizu Teodoro ^a,b,c   Irigoyen, Maria Claudia ^a,b,c   Philips, Michael Ian ^c   de Oliveira, Edilamar Menezes ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF ESPÍRITO SANTO   (Brazil)

^c KECK GRADUATE INSTITUTE   (United States)

Author keywords

Aerobic training; Cardiac hypertrophy; MyomiRs

Indexed keywords

HETEROCHROMATIN PROTEIN 1; HETEROCHROMATIN PROTEIN 1 BETA; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; MICRORNA; MICRORNA 208; MICRORNA 208A; MICRORNA 208B; MYOSIN HEAVY CHAIN; MYOSIN HEAVY CHAIN ALPHA; MYOSIN HEAVY CHAIN BETA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; SMALL UNTRANSLATED RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MED13; TRANSCRIPTION FACTOR PUR BETA; TRANSCRIPTION FACTOR SOX6; TRANSCRIPTION FACTOR SP; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG;

AEROBIC EXERCISE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIASTOLE; EPIGENETICS; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE METABOLISM; HEART VENTRICLE HYPERTROPHY; NONHUMAN; PRIORITY JOURNAL; RAT; SWIMMING; TRANSCRIPTION REGULATION;

EID: 85014106362     PISSN: 01435221     EISSN: 14708736     Source Type: Journal    
DOI: 10.1042/CS20160480     Document Type: Article

References (42)

1. Hill, J.A. and Olson, E.N. (2008) Cardiac plasticity. N. Engl. J. Med. 358, 1370-1380.
2. Weiss, A. and Leinward, L.A. (1996) The mammalian myosin heavy chain gene family. Annu. Rev. Cell Dev. Biol. 12, 417-439.
3. Iemitsu, M., Miyauchi, T., Maeda, S., Sakai, S., Kobayashi, T. and Fujii, N. (2001) Physiological and pathological cardiac hypertrophy induce different molecular phenotypes in the rat. Am. J. Physiol. Regul. Integr. Comp. Physiol. 281, R2029-R2036.
4. Bernardo, B.C., Weeks, K.L., Pretorius, L. and McMullen, J.R. (2010) Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol. Ther. 128, 191-227.
5. Tham, Y.K., Bernardo, B.C., Ooi, J.Y., Weeks, K.L. and McMullen, J.R. (2015) Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch. Toxicol. 89, 1401-1438.
6. Van Rooij, E., Quiat, D., Johnson, B.A., Sutherland, L.B., Qi, X., Richardson, J.A., Kelm, Jr, R.J. and Olson, E.N. (2009) A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev. Cell 17, 662-673.
7. Van Rooij, E., Sutherland, L.B., Qi, X., Richardson, J.H. and Olson, E.N. (2007) Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579.
8. Grueter, C.E., Van Rooij, E., Johnson, B.A., DeLeon, S.M., Sutherland, L.B., Qi, X., Gautron, L., Elmquist, J.K., Bassel-Duby, R. and Olson, E.N. (2012) A cardiac microRNA governs systemic energy homeostasis by regulation of MED13. Cell 149, 671-683.
9. Montgomery, R.L., Hullinger, T.G., Semus, H.M., Brent, A., Dickinson, B.S., Seto, A.G., Lynch, J.M., Stack, C., Latimer, P.A., Olson, E.N. and van Rooij, E. (2011) Therapeutic inhibition of miR-208a improves cardiac function and survival during heart failure. Circulation 124, 1537-1547.
10. Callis, T.E., Pandya, K., Seok, H.Y., Tang, R.H., Tatsuguchi, M., Huang, Z.P., Chen, J.F., Deng, Z., Gunn, B., Shumate, J. et al. (2009) MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J. Clin. Invest. 119, 2772-2786.
11. Satoh, M., Minami, Y., Takahashi, Y., Tabuchy, T. and Nakamura, M. (2010) Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cadiomyopathy. J. Card. Fail. 16, 404-410.
12. Soci, U.P., Fernandes, T., Hashimoto, N.Y., Mota, G.F., Amadeu, M.A., Rosa, K.T., Irigoyen, M.C., Phillips, M.I. and Oliveira, E.M. (2011) MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol. Genomics 43, 665-673.
13. Fernandes, T., Hashimoto, N.Y., Magalhães, F.C., Fernandes, F.B., Casarini, D.E., Carmona, A.K., Krieger, J.E., Phillips, M.I. and Oliveira, E.M. (2011) Aerobic exercise training-induced left ventricular hypertrophy involves regulatory MicroRNAs decreased angiotensin-converting enzyme II and synergistic regulation of angiotensin-converting enzyme 2-angiotensin (1-7). Hypertension 58, 182-189.
14. Da Silva Junior, N.D., Fernendes, T., Soci, U.P., Monteiro, A.W., Phillips, M.I. and De Oliveira, E.M. (2012) Swimming training in rats increases cardiac microRNA-126 expression and angiogenesis. Med. Sci. Sports Exerc. 44, 1453-1462.
15. Fernandes, T., Magalhães, F.C., Roque, F.R., Phillips, M.I. and Oliveira, E.M. (2012) Exercise training prevents the microvascular rarefaction in hypertension balancing angiogenic and apoptotic factors: role of microRNAs-16, 21 and 126. Hypertension 59, 513-520.
16. Melo, S.F., Fernandes, T., Barauna, V.G., Matos, K.C., Santos, A.A. and Tucci, P.J. (2014) Expression of MicroRNA-29 and collagen in cardiac muscle after swimming training in myocardial-infarcted rats. Cell Physiol. Biochem. 33, 657-669.
17. Melo, S.F., Barauna, V.G., Júnior, M.A., Bozi, L.H., Drummond, L.R., Natali, A.J. and de Oliveira, E.M. (2015) Resistance training regulates cardiac function through modulation of miRNA-214. Int. J. Mol. Sci. 16, 6855-6867.
18. Lu, Y.L., Jing, W., Feng, L.S., Zhang, L., Xu, J.F., You, T.J. and Zhao, J. (2014) Effects of hypoxic exercise training on microRNA expression and lipid metabolism in obese rat livers. J. Zhejiang Univ. Sci. B 15, 820-829.
19. Riedel, S., Radzanowski, S., Bowen, T.S., Werner, S., Erbs, S., Schuler, G. and Adams, V. (2015) Exercise training improves high-density lipoprotein-mediated transcription of proangiogenic microRNA in endothelial cells. Eur. J. Prev. Cardiol. 22, 899-903.
20. Fernandes, T., Baraúna, V.G., Negrão, C.E., Phillips, M.I. and Oliveira, E.M. (2015) Aerobic exercise training promotes physiological cardiac remodeling involving a set of microRNAs. Am. J. Physiol. Heart. Circ. Physiol. 309, H543-H552.
21. Sahn, D.J., DeMaria, A., Kisslo, J. and Weyman, A. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58, 1072-1083.
22. Urhausen, A. and Kindermann, W. (1999) Sports-specific adaptations and differentiation of the athlete's heart. Sports Med 28, 237-244.
23. Schiano, C., Casamassimi, A., Vietri, M.T., Rienzo, M. and Napoli, C. (2014) The roles of mediator complex in cardiovascular diseases. Biochim. Biophys. Acta 1839, 444-451.
24. Azakie, A., Fineman, J.R. and Youping, H. (2006) SP3 inhibits Sp1-mediated activation of the cardiac troponin T promoter and is downregulated during pathological cardiac hypertrophy in vivo. Am. J. Physiol. Heart Circ. Physiol. 291, H600-H611.
25. Munari, F., Rezaei-Ghaleh, N., Xiang, S., Fischle, W. and Zweckstetter, M. (2013) Structural plasticity in human heterochromatin protein 1ß. PLoS One 8, e60887.
26. Yang, X.J. and Seto, E. (2008) Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31, 449-461.
27. Gupta, M.P., Samant, S.A., Smith, S.H. and Shroff, S.G. (2008) HDAC4 and PCAF bind to cardiac sarcomeres and play a role in regulating myofilament contractile activity. J. Biol. Chem. 283, 10135-10146.
28. Glozak, M.A., Sengupta, N., Zhang, X. and Seto, E. (2005) Acetylation and deacetylation of non-histone proteins. Gene 363, 15-23.
29. Montgomery, R.L., Davis, C.A., Potthoff, M.J., Haberland, M., Fielitz, J., Qi, X., Hill, J.A., Richardson, J.A. and Olson, E.N. (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21, 1790-1802.
30. Lehmann, L.H., Worst, B.C., Stanmore, D.A. and Backs, J. (2014) Histone deacetylase signaling in cardioprotection. Cell Mol. Life Sci. 71, 1673-1690.
31. Cox, E.J. and Marsh, S.A. (2013) Exercise and diabetes have opposite effects on the assembly and O-GlcNAc modification of the mSin3A/HDAC1/2 complex in the heart. Cardiovasc. Diabetol. 12, 101.
32. Ahringer, J. (2000) NuRD and SIN3 histone deacetylase complexes in development. Trends Genet. 16, 351-356.
33. Trivedi, C.M. (2008) Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy. J. Biol. Chem. 283, 26484-26489.
34. Samant, S.A., Pillai, V.B., Sundaresan, N.R., Shroff, S.G. and Gupta, M.P. (2015) Histone deacetylase 3 (HDAC3)-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity. J. Biol. Chem. 290, 15559-15569.
35. Lehmann, L.H., Worst, B.C., Stanmore, D.A. and Backs, J. (2014) Histone deacetylase signaling in cardioprotection. Cell Mol. Life Sci. 71, 1673-1690.
36. Backs, J., Song, K., Bezprozvannaya, S., Chang, S. and Olson, E.N. (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864.
37. Backs, J., Backs, T., Neef, S., Kreusser, M.M., Lehmann, L.H., Patrick, D.M., Grueter, C.E., Qi, X., Richardson, J.A., Hill, J.A. et al. (2009) The delta isoform of CaM kinase II is required for pathological cardiac hypertrophy and remodeling after pressure overload. Proc. Natl. Acad. Sci. U.S.A. 106, 2342-2347.
38. Zhang, M., Hagenmueller, M., Riffel, J.H., Kreusser, M.M., Bernhold, E., Fan, J., Katus, H.A., Backs, J. and Hardt, S.E. (2015) Calcium/calmodulin-dependent protein kinase II couples Wnt signaling with histone deacetylase 4 and mediates dishevelled-induced cardiomyopathy. Hypertension 65, 335-344.
39. Backs, J., Song, K., Bezprozvannaya, S., Chang, S. and Olson, E.N. (2006) CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. J. Clin. Invest. 116, 1853-1864.
40. Zhang, Y., Matkovich, S.J., Duan, X., Gold, J.I., Koch, W.J. and Dorn, 2nd, G.W. (2011) Nuclear effects of G-protein receptor kinase 5 on histone deacetylase 5-regulated gene transcription in heart failure. Circ. Heart Fail. 4, 659-668.
41. Xu, W.P., Yao, T.Q., Jiang, Y.B., Zhang, M.Z., Wang, Y.P., Yu, Y., Li, J.X. and Li, Y.G. (2015) Effect of the angiotensin II receptor blocker valsartan on cardiac hypertrophy and myocardial histone deacetylase expression in rats with aortic constriction. Exp. Ther. Med. 9, 2225-2228.
42. Neels, J.G. and Grimaldi, P.A. (2014) Physiological functions of peroxisome proliferator-activated receptor ß. Physiol. Rev. 94, 795-858.